- Home
- MTSR
MTSR
METSERA INC
as 04-18-2025 1:40pm EST
Stocks
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 2025 |
| Target Price: | $47.00 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.30 - $32.81 | Next Earning Date: | 05-26-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest METSERA INC News
MTSR Breaking Stock News: Dive into MTSR Ticker-Specific Updates for Smart Investing
MT Newswires
24 days ago
Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher
GlobeNewswire
24 days ago
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
Insider Monkey
a month ago
Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month
Insider Monkey
a month ago
Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?
Insider Monkey
2 months ago
Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently
Thomson Reuters StreetEvents
2 months ago
Q4 2024 Amneal Pharmaceuticals Inc Earnings Call
GlobeNewswire
2 months ago
Metsera to Present at TD Cowen’s 45th Annual Health Care Conference
Investing.com
2 months ago
Wall Street bullish on Metsera following January IPO on obesity drug pipeline
Compare MTSR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MTSR METSERA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.